4548 Stock Overview
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Seikagaku Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥735.00 |
| 52 Week High | JP¥857.00 |
| 52 Week Low | JP¥726.00 |
| Beta | 0.25 |
| 1 Month Change | -4.55% |
| 3 Month Change | -4.79% |
| 1 Year Change | -10.80% |
| 3 Year Change | -27.08% |
| 5 Year Change | -39.85% |
| Change since IPO | -65.98% |
Recent News & Updates
Shareholder Returns
| 4548 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.3% | 0.5% | -0.5% |
| 1Y | -10.8% | 3.1% | 28.3% |
Return vs Industry: 4548 underperformed the JP Pharmaceuticals industry which returned 4.7% over the past year.
Return vs Market: 4548 underperformed the JP Market which returned 31% over the past year.
Price Volatility
| 4548 volatility | |
|---|---|
| 4548 Average Weekly Movement | 1.7% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4548 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4548's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 976 | Ken Mizutani | www.seikagaku.co.jp |
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation.
Seikagaku Corporation Fundamentals Summary
| 4548 fundamental statistics | |
|---|---|
| Market cap | JP¥40.10b |
| Earnings (TTM) | JP¥1.31b |
| Revenue (TTM) | JP¥34.68b |
30.6x
P/E Ratio1.2x
P/S RatioIs 4548 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4548 income statement (TTM) | |
|---|---|
| Revenue | JP¥34.68b |
| Cost of Revenue | JP¥17.16b |
| Gross Profit | JP¥17.52b |
| Other Expenses | JP¥16.21b |
| Earnings | JP¥1.31b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 23.99 |
| Gross Margin | 50.52% |
| Net Profit Margin | 3.77% |
| Debt/Equity Ratio | 0.4% |
How did 4548 perform over the long term?
See historical performance and comparison